Nanalysis Reports Record Revenue and Growth in 2024

An announcement from Nanalysis Scientific ( (TSE:NSCI) ) is now available.

Nanalysis Scientific Corp. reported record revenue and adjusted EBITDA for the fourth quarter and full year 2024, with a 25% increase in quarterly revenue to $12.3 million and a 60% growth in annual revenue to $45 million. The company’s growth is attributed to its strategic focus on expanding core business segments, improving manufacturing efficiencies, and transitioning airport security services to its control, resulting in improved gross margins and positive adjusted EBITDA.

More about Nanalysis Scientific

Nanalysis Scientific Corp. is a leader in portable NMR spectrometers and MRI technology, catering to industrial and research applications. The company focuses on product sales and security services, offering best-in-class Benchtop NMR products and a world-class service organization.

YTD Price Performance: 2.73%

Average Trading Volume: 10,046

Technical Sentiment Signal: Buy

Current Market Cap: $25.71M

See more insights into NSCI stock on TipRanks’ Stock Analysis page.